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Introduction 
Basal cell carcinoma (BCC) is a slow growing, 
locally invasive neoplasm which rarely metastasizes 
to distant organs. Lungs are rarely involved, but even 
more rare are endobronchial metastases. We report a 
patient with recurrent obstructive pneumonia in the 
left lower lobe due to endobronchial localization of 
the metastasis. 
Case Report 
A 59-year-old woman, non-smoker, housewife, 
was admitted to the Pulmonary Department in 
August 1992 with fever, cough and haemoptysis. She 
had similar episodes over the previous 6 months 
which were resolved with antibiotic treatment. 
Three years earlier an ulcerated skin lesion was 
observed in the left axillary area. The lesion was 
surgically excised and histologic examination dis- 
closed adenoid basal cell carcinoma (BCC). One year 
later recurrence was evident in the same region and a 
second and more extensive surgical intervention with 
amputation of the left arm was attempted because of 
perineural and perivascular invasion. The patient 
remained well for 18 months when pneumonia in the 
left lower lobe was diagnosed. 
On examination, the patient was an obese woman, 
with complete amputation of the left arm, who 
appeared ill. Her temperature’ was 3%4”C, blood 
pressure 120/80 mmHg, heart rate 95 beats min ~ ’ 
and respirations 20 min ~ ‘. The surgical scar showed 
no ulcerations and no lymph nodes were palpable. 
The rest of the clinical examination was negative, 
except for rales on auscultation of the posterior of the 
lower left hemithorax. 
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Plate I Posteroanterior (A) and lateral (B) radiogram 
shows an homogenous opacity in the posterior segment of 
the left lower lobe; absence of the left arm is evident. 
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Plate 2 Computerized tomography reveals a mass 4 cm in diameter in the posterior segment of the left lower lobe; 
amputation of the left arm is also evident. 
Plate 3 Histology of the endobronchial mass: basal cell carcinoma, adenoid type (H and E). 
Erythrocyte sedimentation rate (ESR) was 
66 mm h - r, white cell count 6.9 x lo9 l- ‘. The other 
laboratory tests were within normal limits. Mantoux 
tuberculin test was negative. Arterial blood gases 
in room air were: PaO, 8.6 kPa, PaCO, 4.2 kPa, 
pH 744 U. 
Chest radiogram showed an homogenous opacity 
of the posterior bronchopuhnonary segment of the 
left lower lobe without air bronchogram (Plate 1). 
CT-scan disclosed a 4 cm mass occupying the entire 
posterior segment of the left lower lobe; no lymph 
nodes were evident (Plate 2). 
Fibreoptic bronchoscopy showed a polypoid 
mass, totally occluding the posterior basal segmental 
bronchus. Endobronchial biopsy revealed tubular 
gland-like structures, with cells arranged in inter- 
twining strands around islands of connective tissue, 
resulting in a lacelike pattern (Plate 3). These findings 
are compatible with adenoid basal cell carcinoma 
(BCC). 
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The final diagnosis was lung metastasis from 
BCC. 
The patient refused surgery. She was treated with 
radiotherapy and is still alive and in fairly good 
health 12 months after the diagnosis. 
Discussion 
Basal cell carcinoma (BCC), the most common 
form of skin cancer in humans, is a slow-growing, 
locally invasive neoplasm which rarely gives distant 
metastases. The incidence of metastasis has been 
calculated to be between 0.0028% and 0.1% in differ- 
ent centres (1,2). The low incidence of metastatic 
BCC seems to be related to the stromal dependence 
of basal cells that cannot survive without this mutual 
relationship (3). Up to 1991 there have been 257 cases 
of metastatic BCC reported (2). 
The typical case history of a metastatic BCC is that 
of a large, ulcerated, locally invasive and destructive 
primary lesion that has recurred despite repeated 
surgical procedures, radiotherapy or other treatment 
(4). Most observers have found no specific histologic 
type of BCC that is more capable of metastasizing 
than others (5,6). However, some authors assert that 
the basosquamous type of BCC is the most likely to 
metastasize (7). Among the pure BCCs the histo- 
logical types which metastasize more frequently are 
morpheaform, adenocystic and metatypical (7,8). 
Our patient had adenoid type BCC, locally very 
aggressive. 
Eighty-eight percent of primary tumours which 
metastasize are located on the head and neck (7); the 
axilla has been reported once as the site of the 
primary lesion of metastasizing basal cell carcinoma 
(MBCC) (2). The average interval from the onset of 
the primary tumour to the time of metastases is 
reported to be 9.6 yr (7). Survival after signs of 
metastasis ranges from < 1-192 months (9); the aver- 
age survival time is 8 months (9). Metastases in 70% 
of cases occurred in the lymph nodes, 20% in the 
lungs, 18% in the liver and 17% in the bones (10). 
Secondary neoplastic infiltration of the bronchial 
wall, of any histological type of cancer, is usually 
caused by direct extension from either a parenchy- 
ma1 tumour or an involved lymph node in the 
hilum or mediastinum or by a more or less diffuse 
mucosal infiltration, as part of lymphangitic carci- 
nomatosis. The majority of cases are incidental 
microscopic findings observed by the pathologist 
at autopsy. Occasionally, however, involvement of 
a bronchial wall may be relatively well localized, 
and considerable intraluminal growth can then 
occur (11). The commonest extrathoracic cancers 
presenting this way are breast, colorectum, kidney 
and malignant melanoma. However, to our knowl- 
edge, no mention of solitary, obstructive endobron- 
chial metastasis from BCC has been previously 
reported. 
In conclusion, lung metastasis and pneumonitis 
secondary to bronchial obstruction may be an 
unusual mode of presentation of metastasizing BCC 
of the adenoid type. 
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